Top 10 Medical Stocks To Own For 2018

The state of New York just made a huge leap forward with medical marijuana – and the U.S. Department of Veteran Affairs, or VA, is not happy about it.

But it doesn’t matter. The VA stands no chance against medical marijuana’s insane trajectory.

Over the weekend, NY Gov. Andrew Cuomo signed new legislation that allows those in the state with post-traumatic stress disorder (PTSD) to use marijuana to treat symptoms. The bill has been touted as a boon for veterans in particular.

“Our veterans risked their lives in order to defend the ideals and principles that this nation was founded upon, and it is our duty to do everything we can to support them when they return home,” said Cuomo, according to The Associated Press.

New York is the 28th state to legalize medical marijuana for PTSD, and this legislation is in direct opposition to the VA’s negative stance on weed.

Never miss a single marijuana industry update again. To get real-time news sent directly to your inbox,sign up with one click here.

Top 10 Medical Stocks To Own For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Medical Stocks To Own For 2018: Invesco Municipal Opportunity Trust(VMO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Invesco Van Kampen Municpl Opprtnty Trst (NYSE:VMO) declared a monthly dividend on Tuesday, April 3rd, Wall Street Journal reports. Shareholders of record on Tuesday, April 17th will be paid a dividend of 0.0554 per share by the investment management company on Monday, April 30th. This represents a $0.66 dividend on an annualized basis and a dividend yield of 5.66%. The ex-dividend date of this dividend is Monday, April 16th.

Top 10 Medical Stocks To Own For 2018: Treehouse Foods, Inc.(THS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Peel Hunt reaffirmed their buy rating on shares of Tharisa (LON:THS) in a research report released on Tuesday morning. They currently have a GBX 230 ($3.12) price target on the stock.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)
  • [By Paul Ausick]

    Treehouse Foods Inc. (NYSE: THS) fell about 15.5% Thursday to post a new 52-week low of $36.35 after closing at $43.01 on Wednesday. The 52-week high is $90.42. Volume of about 4.8 million was more than four times the daily average. The food processing company posted poor results this morning and announced that it is closing one of its plants.

Top 10 Medical Stocks To Own For 2018: Maximus, Inc.(MMS)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
    AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
    Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
    Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
    Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
    Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
    Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
    Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
    ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
    Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
    Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
    Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
    NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
    World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
    MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
    Choice Hotels International, Inc. (NYSE: CH
  • [By Shane Hupp]

    Maximus (NYSE:MMS) updated its FY18 earnings guidance on Thursday. The company provided EPS guidance of $3.30-3.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.49. The company issued revenue guidance of $2.4-2.44 billion, compared to the consensus revenue estimate of $2.50 billion.

  • [By Logan Wallace]

    Maximus (NYSE:MMS) had its price target decreased by Canaccord Genuity from $65.00 to $64.00 in a research report sent to investors on Friday. Canaccord Genuity currently has a hold rating on the health services provider’s stock.

Top 10 Medical Stocks To Own For 2018: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By Todd Campbell]

    Because statins are so widely used, they’re the most prescribed medicines in the world, and that’s been a bonanza for companies like Pfizer (NYSE:PFE), which developed top-selling cholesterol drug Lipitor, and Merck & Co. (NYSE:MRK), which created cholesterol-lowering add-on therapy Zetia.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Merck & Co., Inc. (NYSE: MRK) which rose about 6% to $62.19. The stocks 52-week range is $53.63 to $66.80. Volume was 43 million compared to its average volume of 12.3 million.

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) traded up 1.80% at $58.64. The stock’s 52-week range is $53.63 to $66.80. Volume was about 25% below the daily average of around 12.1 million shares. The company had no specific news.

  • [By ]

    Merck (NYSE: MRK) has also battled falling sales for its Hyzaar drug but could see renewed interest in the diuretics medication for hypertension patients. Sales in 2017 were $484 million compared to annual revenue of nearly $2 billion before the patent expiration in 2011.

  • [By JJ Kinahan]

    Earnings season slows down a little bit next week, although there are still quite a few major reports on tap:

    Pfizer Inc. (NYSE: PFE) and Merck & Co., Inc. (NYSE: MRK) both report before the open on Tuesday, May 1
    Apple Inc. (NASDAQ: AAPL) reports after the close on Tuesday, May 1
    Tesla Inc. (NASDAQ: TSLA) reports after the close on Wednesday, May 2
    Alibaba Group Holding Inc. (NYSE: BABA) reports before the open on Friday, May 4

    Next week the Fed will also be meeting on May 1-2. There isn’t expected to be a whole lot new coming out of that meeting and there’s a 93 percent probability the Fed won’t hike rates, according to the CME FedWatch tool. If you have time, check out today’s market update for a look at what else is going on.

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) traded down 2.27% at $55.01. The stock’s 52-week range is $53.36 to $66.80. Volume was around 9.66 million shares, about 20% lower than the daily average of about 13 million. The company saw a $2.5 billion award disappear as a judge tossed the verdict against Gilead related to a hepatitis treatment.

Top 10 Medical Stocks To Own For 2018: Navios Maritime Holdings Inc.(NM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Navios Maritime Holdings Inc. (NYSE: NM) is estimated to report quarterly loss at $0.23 per share on revenue of $128.00 million.

    Virtusa Corporation (NASDAQ: VRTU) is projected to report quarterly earnings at $0.55 per share on revenue of $279.85 million.

  • [By Joseph Griffin]

    Navios Maritime (NYSE: NM) is one of 44 public companies in the “Deep sea foreign transportation of freight” industry, but how does it contrast to its peers? We will compare Navios Maritime to similar companies based on the strength of its earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Navios Maritime (NM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2018: Marcus Corporation (MCS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Marcus (NYSE: MCS) and AMC Entertainment (NYSE:AMC) are both consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.

  • [By Max Byerly]

    In other news, VP Thomas F. Kissinger sold 10,000 shares of Marcus stock in a transaction dated Wednesday, March 7th. The stock was sold at an average price of $29.12, for a total value of $291,200.00. Following the transaction, the vice president now owns 81,664 shares in the company, valued at $2,378,055.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Diane M. Gershowitz sold 12,750 shares of the firm’s stock in a transaction dated Friday, April 6th. The stock was sold at an average price of $30.86, for a total value of $393,465.00. Following the completion of the sale, the director now directly owns 7,482 shares in the company, valued at $230,894.52. The disclosure for this sale can be found here. Insiders have sold 44,250 shares of company stock valued at $1,343,255 in the last three months. 32.88% of the stock is owned by corporate insiders.

    ILLEGAL ACTIVITY WARNING: “Barrington Research Brokers Lower Earnings Estimates for Marcus Co. (MCS)” was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3367299/barrington-research-brokers-lower-earnings-estimates-for-marcus-co-mcs.html.

    Marcus Company Profile

  • [By Ethan Ryder]

    AMC Entertainment (NYSE: AMC) and Marcus (NYSE:MCS) are both consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Top 10 Medical Stocks To Own For 2018: Innodata Inc.(INOD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Innodata (NASDAQ:INOD) will be releasing its Q1 2018 earnings data before the market opens on Tuesday, May 8th.

    Innodata (NASDAQ:INOD) last announced its earnings results on Thursday, March 8th. The technology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $15.66 million for the quarter. Innodata had a negative return on equity of 10.94% and a negative net margin of 8.30%.

Top 10 Medical Stocks To Own For 2018: Brown Forman Corporation(BF.B)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Brown-Forman (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2018: Simpson Manufacturing Company Inc.(SSD)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Simpson Manufacturing (SSD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Simpson Manufacturing (SSD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Simpson Manufacturing (NYSE:SSD) has been assigned an average rating of “Hold” from the six brokerages that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $64.25.